Applying of Hierarchical Clustering to Analysis of Protein Patterns in the Human Cancer-Associated Liver
暂无分享,去创建一个
Oxana P. Trifonova | G. P. Kuznetsova | Mikhail A. Pyatnitskiy | O. V. Larina | Natalia A. Petushkova | Vladislav A. Rudenko | Olesya V. Larina | Julya S. Kisrieva | Natalia F. Samenkova | Galina P. Kuznetsova | Irina I. Karuzina | Andrey V. Lisitsa | A. Lisitsa | I. Karuzina | M. Pyatnitskiy | O. Trifonova | N. Petushkova | J. S. Kisrieva | N. Samenkova | Vladislav A. Rudenko
[1] William M. Rand,et al. Objective Criteria for the Evaluation of Clustering Methods , 1971 .
[2] S. Mocellin,et al. Colorectal liver metastasis: towards the integration of conventional and molecularly targeted therapeutic approaches. , 2005, Frontiers in bioscience : a journal and virtual library.
[3] T Voss,et al. Observations on the reproducibility and matching efficiency of two‐dimensional electrophoresis gels: Consequences for comprehensive data analysis , 2000, Electrophoresis.
[4] Rachana Jain,et al. Kolmogorov-Smirnov scores and intrinsic mass tolerances for peptide mass fingerprinting. , 2010, Journal of proteome research.
[5] Xiaokui K. Zhang,et al. Loss of carbamoyl phosphate synthetase I in small-intestinal adenocarcinoma. , 2009, American journal of clinical pathology.
[6] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[7] J. Celis,et al. 2D protein electrophoresis: can it be perfected? , 1999, Current opinion in biotechnology.
[8] D. Klinke,et al. Inferring predominant pathways in cellular models of breast cancer using limited sample proteomic profiling , 2010, BMC Cancer.
[9] J. Keating,et al. Overexpression of aminoacylase 1 is associated with colorectal cancer progression. , 2013, Human pathology.
[10] N. Karp,et al. Design and Analysis Issues in Quantitative Proteomics Studies , 2007, Proteomics.
[11] K. Do,et al. Dicarbonyl/l-Xylulose Reductase: A Potential Biomarker Identified by Laser-Capture Microdissection-Micro Serial Analysis of Gene Expression of Human Prostate Adenocarcinoma , 2007, Cancer Epidemiology Biomarkers & Prevention.
[12] M. Schuelke,et al. Quantitative and qualitative 2D electrophoretic analysis of differentially expressed mitochondrial proteins from five mouse organs , 2013, Proteomics.
[13] W. Ha,et al. Proteome analysis of human liver tumor tissue by two‐dimensional gel electrophoresis and matrixassisted laser desorption/ionization‐mass spectrometry for identification of disease‐related proteins , 2002, Electrophoresis.
[14] U. Settmacher,et al. Identification of specific protein markers in microdissected hepatocellular carcinoma. , 2007, Journal of proteome research.
[15] Hoguen Kim,et al. Suppression of human selenium‐binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival , 2006, Proteomics.
[16] M. Choti,et al. Liver-directed therapies in colorectal cancer. , 2011, Seminars in oncology.
[17] N. Kemeny,et al. Molecular therapies for colorectal cancer metastatic to the liver. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.
[18] Wancai Yang,et al. Transcriptional Regulation and Biological Functions of Selenium-Binding Protein 1 in Colorectal Cancer In Vitro and in Nude Mouse Xenografts , 2009, PloS one.
[19] David Fenyö,et al. Optimizing search conditions for the mass fingerprint‐based identification of proteins , 2006, Proteomics.
[20] J. Treluyer,et al. Pharmacogenomics of Fluorouracil, Irinotecan, and Oxaliplatin in Hepatic Metastases of Colorectal Cancer , 2005, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.
[21] J. Casal,et al. Proteome analysis of membrane fractions in colorectal carcinomas by using 2D-DIGE saturation labeling. , 2008, Journal of proteome research.
[22] Computational approach to characterization of human liver drug-metabolizing enzymes. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[23] Kelvin H Lee,et al. Quantitative and qualitative measure of intralaboratory two‐dimensional protein gel reproducibility and the effects of sample preparation, sample load, and image analysis , 2003, Electrophoresis.
[24] Markus Absenger,et al. Aldehyde Dehydrogenase 1, a Potential Marker for Cancer Stem Cells in Human Sarcoma , 2012, PloS one.
[25] A. Lisitsa,et al. Selection of the peptide mass tolerance value for protein identification with peptide mass fingerprinting , 2011, Russian Journal of Bioorganic Chemistry.
[26] D. Arango,et al. Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. , 2008, Molecular nutrition & food research.
[27] A. Shevchenko,et al. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.
[28] P. An,et al. Comparative study of proteome between primary cancer and hepatic metastatic tumor in colorectal cancer. , 2004, World journal of gastroenterology.
[29] C. Avellini,et al. Differential proteomic analysis of hepatocellular carcinoma. , 2010, International journal of oncology.
[30] P. F. Macgregor,et al. Application of microarrays to the analysis of gene expression in cancer. , 2002, Clinical chemistry.
[31] John Quackenbush,et al. Synchronous global assessment of gene and protein expression in colorectal cancer progression. , 2005, Genomics.
[32] Yukiko Nakamura,et al. Global expression study in colorectal cancer on proteins with alkaline isoelectric point by two-dimensional difference gel electrophoresis. , 2011, Journal of proteomics.
[33] S. Gammeltoft,et al. Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study , 2005, BMC Cancer.
[34] G. Meijer,et al. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers. , 2010, Journal of proteomics.
[35] Xiayu Li,et al. New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancer. , 2012, Molecular bioSystems.
[36] R. Stubbs,et al. Proteomic analysis of advanced colorectal cancer by laser capture microdissection and two-dimensional difference gel electrophoresis. , 2011, Journal of proteomics.
[37] Syed A. Ahmad,et al. Colon cancer angiogenesis and antiangiogenic therapy , 2004, Expert opinion on investigational drugs.
[38] er I Archakov,et al. Optimization of the SDS-PAGE gel slicing approach for identification of human liver microsomal proteins via MALDI-TOF mass spectrometry , 2012 .
[39] T. Mohr,et al. Introducing the CPL/MUW proteome database: Interpretation of human liver and liver cancer proteome profiles by referring to isolated primary cells , 2009, Electrophoresis.
[40] C. Hellerbrand,et al. Cell characterization by proteome profiling applied to primary hepatocytes and hepatocyte cell lines Hep-G2 and Hep-3B. , 2010, Journal of proteome research.
[41] E. Mariman,et al. Potential protein markers for nutritional health effects on colorectal cancer in the mouse as revealed by proteomics analysis , 2006, Proteomics.